Breast cancer and other second neoplasms after childhood Hodgkin's disease

New England Journal of Medicine

Volumn 334, Issue 12, 1996, Pages 745-751

  Bhatia, Smita ^a   Robison, Leslie L ^a,f   Oberlin, Odile ^b   Greenberg, Mark ^c   Bunin, Greta ^d   Fossati Bellani, Franca ^e   Meadows, Anna T ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SECOND CANCER;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CHILD; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; LEUKEMIA; LYMPHOMA; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; RISK; RISK FACTORS;

EID: 0029877511     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199603213341201     Document Type: Article

References (44)

1. Devita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970;73:881-95
2. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304: 1377-82.
3. Sherins RJ, DeVita VT Jr Effect of drug treatment for lymphoma on male reproductive capacity: studies of men in remission after therapy. Ann Intern Med 1973,79.216-20.
4. Rosenberg SA, Kaplan HS The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease. 1962-1984. Int J Radiat Oncol Biol Phys 1985;11.5-22
5. Arseneau JC, Sponzo RW, Levin DL, et al. Nonlymphomatous malignant tumors complicating Hodgkin's disease: possible association with intensive therapy. N Engl J Med 1972,287.1119-22.
6. Canellos GP, Arseneau JC, DeVita VT, Whang-Peng J, Johnson RE. Second malignancies complicating Hodgkin's disease in remission. Lancet 1975;1: 947-9.
7. Coleman CN, Kaplan HS, Cox R, Varghese A, Butterfield P, Rosenberg SA Leukaemias, non-Hodgkin's lymphomas and solid tumours in patients treated for Hodgkin's disease. Cancer Surv 1982;1:733-44.
8. Coltman CA Jr, Dixon DO. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year follow-up Cancer Treat Rep 1982;66 1023-33.
9. Glicksman AS, Pajak TF, Gottlieb JA, Nissen N, Stutzman L, Cooper MR. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study. Cancer Treat Rep 1982,66: 1035-44.
10. Boivin JF, Hutchison GB, Lyden M, Godbold J, Chorosh J, Schottenfeld D Second primary cancers following treatment of Hodgkin's disease J Natl Cancer Inst 1984,72.233-41.
11. Koletsky AJ, Bertino JR, Farber LR, et al. Second neoplasms in patients with Hodgkin's disease following combined modality therapy - the Yale experience. J Clin Oncol 1986;4:311-7.
12. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 1986;4.830-7.
13. Blayney DW, Longo DL, Young RC, et al. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 1987;316:710-4.
14. Pederson-Bjergaard J, Specht L, Larsen SO, et al. Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease: relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 1987;2:83-8
15. Tucker MA, Meadows AT, Boice JD Jr, et al. Leukemia after therapy with alkylating agents for childhood cancer J Natl Cancer Inst 1987;78:459-64
16. Meadows AT, Obringer AC, Marrero O, et al. Second malignant neoplasms following childhood Hodgkin's disease, treatment and splenectomy as risk factors Med Pediatr Oncol 1989;17:477-84.
17. Beaty O III, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995,13.603-9
18. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995;87:732-41.
19. Miller BA, Ries LAG, Hankey BF, et al SEER cancer statistics review: 1973-1990. Bethesda, Md.: National Cancer Institute, 1993. (NIH publication no. 93-2789.)
20. Vandenbroucke JP. A shortcut method for calculating the 95 per cent confidence interval of the standardized mortality ratio. Am J Epidemiol 1982; 115.303-4
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc 1958;53:457-81.
22. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds Cancer incidence in five continents Vol. 6. Lyon, France: International Agency for Research on Cancer, 1992. (IARC scientific publications no. 120.)
23. Mackenzie I. Breast cancer following multiple fluoroscopies. Br J Cancer 1965;19:1-8.
24. Miller AB, Howe GR, Sherman GJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis N Engl J Med 1989,321:1285-9.
25. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B. Breast cancer among women given X-ray therapy for acute post-partum mastitis. J Natl Cancer Inst 1986;77:689-96.
26. Baral E, Larsson LE, Mattson B. Breast cancer following irradiation of the breast. Cancer 1977,40:2905-10.
27. Tokunaga M, Land CE, Yamamoto T, et al. Incidence of female breast cancer among atomic bomb survivors Hiroshima and Nagasaki, 1950-1980 Radiat Res 1987, 112 243-72.
28. Boice JD Jr, Land CE, Shore RE, Norman JE, Tokunaga M Risk of breast cancer following low-dose radiation exposure. Radiology 1979,131:589-97.
29. Cimino G, Papa G, Tura PS, et al. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. J Clin Oncol 1991,9:432-7.
30. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988,318 76-81.
31. Greene MH, Wilson J. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. In: Boice JD Jr, Storm HH, Curtis RE, et al., eds. Multiple primary cancers in Connecticut and Denmark. National Cancer Institute monograph 68. Washington, D.C.. Government Printing Office, 1985:191-7 (NIH publication no. 85-2714.)
32. Storm HH, Prener A. Second cancer after lymphatic and hematopoietic cancers in Denmark, 1943-80. In: Boice JD Jr, Storm HH, Curtis RE, et al , eds Multiple primary cancers in Connecticut and Denmark. National Cancer Institute monograph 68. Washington, D C.. Government Printing Office, 1985.389-409. (NIH publication no. 85-2714.)
33. Kaldor JM, Day NE, Band P, et al Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 1987;39:571-85.
34. Curtis RE, Boice JD Jr. Second cancers after radiotherapy for Hodgkin's disease N Engl J Med 1988;319:244-5.
35. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease J Natl Cancer Inst 1993,85:25-31
36. van Leeuwen FE, Somers R, Hart AAM. Splenectomy in Hodgkin's disease and second leukaemias. Lancet 1987;2:210-1.
37. van der Velden JW, van Putten WLJ, Guinee VF, et al. Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease. Int J Cancer 1988,42:252-5.
38. van Leeuwen FE, Somers R, Taal BG, et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol 1989,7:1046-58.
39. Kaldor JM, Day NE, Clarke EA, et al Leukemia following Hodgkin's disease. N Engl J Med 1990;322:7-13.
40. Tura S, Fiacchini M, Zinzani PL, Brusamolino E, Gobbi PG. Splenectomy and the increasing risk of second acute leukemia in Hodgkin's disease. J Clin Oncol 1993;11:925-30.
41. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease. a 20 year follow-up study. J Clin Oncol 1994;12: 312-25.
42. Andrieu J-M, Ifrah N, Payen C, Fermanian J, Coscas Y, Flandrin G. Increased risk of second acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 1990;8:1148-54.
43. Abrahamsen JF, Andersen A, Hannisdal E, et al. Second malignancies after treatment of Hodgkin's disease. the influence of treatment, follow-up time, and age. J Clin Oncol 1993;11:255-61.
44. Rodriguez MA, Fuller LM, Zimmerman SO, et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol 1993;4:125-31.